Rood Research is categorized under Commercial Medical Research in New York City, NY and active since 2004.
Rood Research was established in 2004, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5416130 by the NAICS.
If you are seeking more information, feel free to contact Edith Rood, Chief Executive Officer at the company’s single location by writing to 114 West 26th St Floor 11, New York City, New York NY 10001 or by phoning (212) 414-9300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rood Research |
| Contact Person: | Edith Rood, Chief Executive Officer |
| Address: | 114 West 26th St Floor 11, New York City, New York 10001 |
| Phone Number: | (212) 414-9300 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5416130 |
| Share This Business: |
Rood Research was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5416130. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Edith Rood, Chief Executive Officer for inquiries that concern Rood Research by calling the company number (212) 414-9300, as your correspondence is most welcome. Additionally, the physical location of the single location of Rood Research can be found at the coordinates 40.744954,-73.991919 as well as the street address 114 West 26th St Floor 11 in New York City, New York 10001.
For its online presence, you may visit Rood Research’s website at and engage with its social media outlets through on Twitter and on Facebook.